About: Margaret A Fischl

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Margaret A Fischl Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідниця (uk) изилдөөчү (ky) հետազոտող (hy)
rdfs:label	Margaret A Fischl (en) Margaret A Fischl (es) Margaret A Fischl (nl) Margaret A Fischl (ast)
skos:prefLabel	Margaret A Fischl (en) Margaret A Fischl (es) Margaret A Fischl (nl) Margaret A Fischl (ast)
name	Margaret A Fischl (en) Margaret A Fischl (es) Margaret A Fischl (nl) Margaret A Fischl (ast)
given name	wds:Q63847562-AB2C3850-ECBF-4848-BDAE-5D17BD6BA46B
given name	Margaret
instance of	wds:Q63847562-8B5FF3D0-E2F0-4470-A594-22468C1AA19A
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q63847562-57F2E136-5943-4BBF-8D64-941DC20DA491
Google Knowledge Graph ID	http://g.co/kg/g/11f0mgvrnv
Google Knowledge Graph ID	/g/11f0mgvrnv
skos:altLabel	Margaret Fischl (en)
occupation	wds:Q63847562-08423CFA-4E80-49F6-B7B3-FAF30DC664AF
sex or gender	wds:Q63847562-018aea96-421f-84df-3879-78a3719eb545
VIAF ID	wds:Q63847562-1662c2ff-4c0a-f413-7aa7-de0e74413363
Library of Congress authority ID	wds:q63847562-51185e94-4013-45e7-6b2f-fffedd6a007b
WorldCat Identities ID (superseded)	wds:q63847562-c2587c33-4d2f-e1fe-3151-9dfb24af1fe3
National Library of Israel J9U ID	wds:q63847562-777d21a2-4004-7d48-3589-0d207075367f
VIAF ID	http://viaf.org/viaf/18925188
Library of Congress authority ID	http://id.loc.gov/authorities/names/n95025216
occupation	researcher
sex or gender	female organism
VIAF ID	18925188
Library of Congress authority ID	n95025216
WorldCat Identities ID (superseded)	lccn-n95025216
National Library of Israel J9U ID	987007318397305171
ORCID iD	wds:Q63847562-E31D7418-D419-49FD-81FF-92E006D76A7E
ORCID iD	https://orcid.org/0000-0001-9241-5390
ORCID iD	0000-0001-9241-5390
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63847562 Margaret Fischl
is author of	The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260) Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South Florida Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Glomerular lesions in the acquired immunodeficiency syndrome Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software